Zobrazeno 1 - 10
of 222
pro vyhledávání: '"M Lodén"'
Autor:
Peter C. Ligthart, Hong Luo, Yanli Ji, Yongshui Fu, C. E. Van Der Schoot, Lonneke Haer-Wigman, M. Lodén-van Straaten, Jizhi Wen, Barbera Veldhuisen, Zhengli Wang, Guangping Luo, Ling Wei
Publikováno v:
Vox Sanguinis, 112, 7, pp. 660-670
Vox Sanguinis, 112, 660-670
Vox sanguinis, 112(7), 660-670. Wiley-Blackwell
Vox Sanguinis, 112, 660-670
Vox sanguinis, 112(7), 660-670. Wiley-Blackwell
Item does not contain fulltext BACKGROUND AND OBJECTIVES: Several comprehensive genotyping platforms for determining red blood cell (RBC) antigens have been established and validated for use in the Caucasian and Black populations, but not for the Chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f84fe429d5a84b68f9b4b5e3c6e6fe7a
https://hdl.handle.net/2066/182650
https://hdl.handle.net/2066/182650
Autor:
M. Lodén, U. Åkerström, M. Matsson, Desiree Wiegleb Edström, H. Beitner, Helena Gonzalez, Hans Christian Wulf, I. Buraczewska-Norin, Joar Austad
Publikováno v:
British Journal of Dermatology. 165:255-262
Mismatches between skin pigmentation and modern lifestyle continue to challenge our naked skin. One of our responses to these challenges is the development and use of sunscreens. The management of sunscreens has to balance their protective effect aga
Autor:
G. Mørk, J. Funk, C. Lützow-Holm, K.T. Smerud, H. Hønnås, Birgitta Meding, K. Wirén, N. Meland, M. Lodén
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 26:597-601
Background Hand eczema is a common and persistent disease with a relapsing course. Clinical data suggest thatonce daily treatment with corticosteroids is just as effective as twice daily treatment.Objectives The aim of this study was to compare once
Autor:
L Holm, M Svensson, M Lodén, P Wallberg, K Wirén, Berit Berne, F Nyberg, Ari Johannesson, C Nohlgård, F Edlund
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 23:1267-1272
Background Standard treatment of atopic dermatitis (AD) is based on topical glucocorticosteroids or calcineurin inhibitors to treat flares combined with moisturizer treatment to alleviate dry skin symptoms. Patients with AD have an abnormal skin barr
Publikováno v:
British Journal of Dermatology. 160:552-556
Summary Background The cosmetic properties of topical formulations are important parameters for the adherence to treatment, where modern oil-in-water emulsions are considered more acceptable compared with ointments. After application of an emulsion t
Publikováno v:
British Journal of Dermatology. 157:82-86
Summary Background Artificial reduction of abnormal transepidermal water loss (TEWL) is considered to improve skin diseases associated with a defective barrier function. Treatment of the skin with moisturizers is also known to influence skin barrier
Autor:
M. Lodén, K. Halvarsson
Publikováno v:
International Journal of Cosmetic Science. 29:69-83
Atopic dermatitis is a chronic relapsing inflammatory skin disease which usually starts during the first years of life. In patients with the disease, the quality of skin is severely affected, and this is closely linked to a reduced quality of life. A
Autor:
Mats Grände, Petra Skare, Sakari Reitamo, Lisbeth Rustad, Tor Langeland, Karin Wiren, Mats Berg, Ulf Åkerström, Laura Korhonen, M Lodén, Åke Svensson
Publikováno v:
Acta Dermato-Venereologica; 95(5), pp 587-592 (2015)
Atopic dermatitis (AD) affects adults and children and has a negative impact on quality of life. The present multicentre randomized double-blind controlled trial showed a barrier-improving cream (5% urea) to be superior to a reference cream in preven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828c91a1438ef26e7eeed10935e3f358
http://hdl.handle.net/10138/161809
http://hdl.handle.net/10138/161809
Autor:
Jitka Malčíková, G.D. te Raa, E. Eldering, Hanneke N. Monsuur, Arnon P. Kater, Alexander Jethwa, Tatjana Stankovic, Ingrid A. M. Derks, Veronika Navrkalová, Šárka Pospíšilová, M. Lodén, Ceri E. Oldreive, Perry D. Moerland, Anna Skowronska, M. H. J. Van Oers, Thorsten Zenz, J van Laar, Martin Trbušek, Christian H. Geisler, Jennifer Hüllein
Publikováno v:
Leukemia, 29(5), 1133-1142. Nature Publishing Group
Leukemia
Leukemia
Mutations or deletions in TP53 or ATM are well-known determinants of poor prognosis in chronic lymphocytic leukemia (CLL), but only account for approximately 40% of chemo-resistant patients. Genome-wide sequencing has uncovered novel mutations in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09caaa3f2be2285402c3f5ed97e53912
https://pure.amc.nl/en/publications/the-impact-of-sf3b1-mutations-in-cll-on-the-dnadamage-response(239e4aef-b5c8-427e-8fb7-f6b090758a1f).html
https://pure.amc.nl/en/publications/the-impact-of-sf3b1-mutations-in-cll-on-the-dnadamage-response(239e4aef-b5c8-427e-8fb7-f6b090758a1f).html
Autor:
M Lodén
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 19:672-688
UNLABELLED Moisturizing creams marketed to consumers often contain trendy ingredients and are accompanied by exciting names and attractive claims. Moisturizers are also an important part of the dermatologist's armamentarium to treat dry skin conditio